Asset Dedication’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$703 Hold
65
– – ﹤0.01% 1091
2026
Q2
$613 Hold
65
– – ﹤0.01% 1142
2026
Q1
$530 Hold
65
– – ﹤0.01% 1050
2025
Q4
$437 Hold
65
– – ﹤0.01% 1090
2025
Q3
$564 Hold
65
– – ﹤0.01% 1095
2025
Q2
$410 Hold
65
– – ﹤0.01% 1131
2025
Q1
$417 Hold
65
– – ﹤0.01% 1069
2024
Q4
$523 Hold
65
– – ﹤0.01% 1047
2024
Q3
$821 Hold
65
– – ﹤0.01% 1070
2024
Q2
$823 Hold
65
– – ﹤0.01% 1114
2024
Q1
$0 Hold
65
– – ﹤0.01% 1026
2023
Q4
$0 Hold
65
– – ﹤0.01% 1033
2023
Q3
$0 Hold
65
– – ﹤0.01% 1034
2023
Q2
$0 Hold
65
– – ﹤0.01% 1015
2023
Q1
$0 Hold
65
– – ﹤0.01% 1033
2022
Q4
$1K Hold
65
– – ﹤0.01% 947
2022
Q3
$1K Buy
+65
New +$2.82K ﹤0.01% 898

Other funds holding NVAX

Asset Dedication's NVAX Position: Q3 2026 in Review

Asset Dedication held its Novavax (NVAX) position steady in Q3 2026 at 65 shares worth $703. The position accounts for ﹤0.01% of the portfolio, ranked #1091.

Asset Dedication first reported a position in NVAX in Q3 2022 and has held it in 17 quarters since. The position peaked at $1K in Q4 2022. 195 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.

  • Asset Dedication held 65 shares of Novavax worth $703 as of Q3 2026.
  • Asset Dedication left its Novavax share count unchanged in Q3 2026.
  • Novavax made up ﹤0.01% of Asset Dedication's portfolio in Q3 2026, its #1091 holding.
  • Asset Dedication first reported a position in Novavax in Q3 2022 and has held it in 17 quarters since.
  • Asset Dedication's Novavax position peaked at $1K in Q4 2022.
  • 195 funds tracked by Wall St. Rank held Novavax as of Q3 2026.

Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.